BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35965412)

  • 1. Targeting N
    Zhu S; Wu Y; Zhang X; Peng S; Xiao H; Chen S; Xu L; Su T; Kuang M
    Mol Ther; 2023 Jun; 31(6):1596-1614. PubMed ID: 35965412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
    Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
    Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL1 promotes hepatocarcinogenesis via m
    Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
    Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
    Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation.
    Zeng X; Liao G; Li S; Liu H; Zhao X; Li S; Lei K; Zhu S; Chen Z; Zhao Y; Ren X; Su T; Cheng AS; Peng S; Lin S; Wang J; Chen S; Kuang M
    Hepatology; 2023 Apr; 77(4):1122-1138. PubMed ID: 35598182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
    Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
    Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WDR4 promotes HCC pathogenesis through N
    Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
    Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL1/WDR4-mediated m
    Ma J; Han H; Huang Y; Yang C; Zheng S; Cai T; Bi J; Huang X; Liu R; Huang L; Luo Y; Li W; Lin S
    Mol Ther; 2021 Dec; 29(12):3422-3435. PubMed ID: 34371184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL1/WDR4-mediated tRNA m
    Wang Z; Yu P; Zou Y; Ma J; Han H; Wei W; Yang C; Zheng S; Guo S; Wang J; Liu L; Lin S
    Oncogene; 2023 Jun; 42(23):1900-1912. PubMed ID: 37185458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL1-mediated tRNA m
    Du D; Zhou M; Ju C; Yin J; Wang C; Xu X; Yang Y; Li Y; Cui L; Wang Z; Lei Y; Li H; He F; He J
    J Exp Clin Cancer Res; 2024 May; 43(1):154. PubMed ID: 38822363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
    Wang F; Xu C; Li G; Lv P; Gu J
    Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma.
    Jiang J; Chen S; Li K; Zhang C; Tan Y; Deng Q; Chai Y; Wang X; Chen G; Feng K; Zhang L; Xie CM; Ma K
    Int J Hyperthermia; 2019; 36(1):499-510. PubMed ID: 31007109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
    Su T; Liao J; Dai Z; Xu L; Chen S; Wang Y; Peng Z; Zhang Q; Peng S; Kuang M
    Oncogene; 2018 Jun; 37(26):3514-3527. PubMed ID: 29559743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mettl1/Wdr4-Mediated m
    Lin S; Liu Q; Lelyveld VS; Choe J; Szostak JW; Gregory RI
    Mol Cell; 2018 Jul; 71(2):244-255.e5. PubMed ID: 29983320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N
    Dai Z; Liu H; Liao J; Huang C; Ren X; Zhu W; Zhu S; Peng B; Li S; Lai J; Liang L; Xu L; Peng S; Lin S; Kuang M
    Mol Cell; 2021 Aug; 81(16):3339-3355.e8. PubMed ID: 34352206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N
    Chen B; Jiang W; Huang Y; Zhang J; Yu P; Wu L; Peng H
    Oncogene; 2022 Apr; 41(15):2239-2253. PubMed ID: 35217794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HSP90 inhibitor, XL888, enhanced cell apoptosis via downregulating STAT3 after insufficient radiofrequency ablation in hepatocellular carcinoma.
    Sun C; Bai M; Ke W; Wang X; Zhao X; Lu Z
    Life Sci; 2021 Oct; 282():119762. PubMed ID: 34186047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1.
    Peng C; Li X; Ao F; Li T; Guo J; Liu J; Zhang X; Gu J; Mao J; Zhou B
    J Transl Med; 2023 Mar; 21(1):218. PubMed ID: 36964576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy.
    Liao J; Yi Y; Yue X; Wu X; Zhu M; Chen Y; Peng S; Kuang M; Lin S; Peng Z
    Hepatology; 2023 Jun; 77(6):1896-1910. PubMed ID: 35698894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Han H; Zheng S; Lin S
    Autophagy; 2023 Jan; 19(1):360-362. PubMed ID: 35574843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.